Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Moodys
Boehringer Ingelheim
AstraZeneca
Harvard Business School
Cantor Fitzgerald
Deloitte
Fuji
Johnson and Johnson

Generated: June 20, 2018

DrugPatentWatch Database Preview

Qol Medcl Company Profile

« Back to Dashboard

What is the competitive landscape for QOL MEDCL, and when can generic versions of QOL MEDCL drugs launch?

QOL MEDCL has two approved drugs.

There is one US patent protecting QOL MEDCL drugs.

There are three patent family members on QOL MEDCL drugs in three countries.

Summary for Qol Medcl
International Patents:3
US Patents:1
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Qol Medcl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Qol Medcl SUCRAID sacrosidase SOLUTION;ORAL 020772-001 Apr 9, 1998 RX Yes Yes 9,469,847 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Qol Medcl ETHAMOLIN ethanolamine oleate INJECTABLE;INJECTION 019357-001 Dec 22, 1988 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Qol Medcl

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,255,261 Ultrapure hypoallergenic solutions of sacrosidase ➤ Try a Free Trial
9,849,161 Ultrapure hypoallergenic solutions of sacrosidase ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Farmers Insurance
US Army
Fuji
Argus Health
Express Scripts
McKinsey
Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.